Link:

Featured Articles

Antiplatelet Therapy: A Review of Three Articles

James J. Ferguson, III, MD
Associate Director, Clinical Cardiology Research, The Texas Heart Institute at St. Luke's Episcopal Hospital
Associate Professor of Medicine, Baylor College of Medicine
Clinical Assistant Professor, The University of Texas Health Science Center at Houston

Patients With Prior Myocardial Infarction, Stroke, or
Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

Deepak L. Bhatt, Marcus D. Flather, Werner Hacke, et al
Reprinted with permission from J Am Coll Cardiol. 2007;49:1982-1988.

Impact of Platelet Reactivity After Clopidogrel
Administration on Drug-Eluting Stent Thrombosis

Piergiovanni Buonamici, Rossella Marcucci, Angela Migliorini, et al
Reprinted with permission from J Am Coll Cardiol. 2007;49:2312-2317.

Variability in Individual Responsiveness to Clopidogrel:
Clinical Implications, Management, and Future Perspectives

Dominick J. Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al
Reprinted with permission from J Am Coll Cardiol. 2007;49:1505-1516.